75,411 resources
By Version
By Authority
By Realm
Start Prev Rows 11000 - 11200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth |
---|---|---|---|---|---|---|---|---|---|
myhealth.eu.fhir.laboratory | R4 | ImplementationGuide/myhealth.eu.fhir.laboratory | MyHealth@Eu Laboratory Report | active | 2025-03 | eu | |||
hl7.fhir.eu.laboratory | R4 | ImplementationGuide/hl7.fhir.eu.laboratory | HL7 Europe Laboratory Report | draft | 2025-07 | eu | hl7 | ||
hl7.fhir.uv.lab-report | R4 | ImplementationGuide/hl7.fhir.uv.lab-report | HL7 Laboratory Report | trial-use | oo | 2025-01 | uv | hl7 | |
hl7.fhir.eu.eps | R4 | ImplementationGuide/hl7.fhir.eu.eps | HL7 Europe Patient Summary | draft | 2025-06 | eu | hl7 | ||
hl7.fhir.eu.mpd-r5 | R5 | ImplementationGuide/hl7.fhir.eu.mpd-r5 | HL7 Europe Medication Prescription and Dispense | draft | 2025-06 | eu | hl7 | ||
hl7.fhir.eu.mpd | R4 | ImplementationGuide/hl7.fhir.eu.mpd | HL7 Europe Medication Prescription and Dispense | draft | 2025-07 | eu | hl7 | ||
ca.infoway.vc.ps | R4 | ImplementationGuide/ca.infoway.vc.ps | Pan-Canadian Patient Summary - FHIR Implementation Guide | draft | 2021-12 | ca | national | ||
hl7.eu.fhir.oah | R4 | ImplementationGuide/hl7.eu.fhir.oah | OneAquaHealth Project | draft | 2025-08 | eu | hl7 | ||
hl7.fhir.eu.extensions | R5 | ImplementationGuide/hl7.fhir.eu.extensions | HL7 Europe Extensions | draft | 2025-08 | eu | hl7 | ||
hl7.fhir.eu.extensions.r5 | R5 | ImplementationGuide/hl7.fhir.eu.extensions.r5 | HL7 Europe Extensions | active | 2025-06 | eu | hl7 | ||
hl7.cda.us.eyecare | R5 | ImplementationGuide/hl7.cda.us.eyecare | Specialty Eyecare CDA Implementation Guide | draft | 2024-02 | us | hl7 | ||
hl7.fhir.us.cancer-reporting | R4 | ImplementationGuide/hl7.fhir.us.cancer-reporting | Cancer Pathology Data Sharing | trial-use | oo | 2025-07 | us | hl7 | |
hl7.fhir.us.health-care-surveys-reporting | R4 | ImplementationGuide/hl7.fhir.us.health-care-surveys-reporting | Health Care Surveys Reporting | draft | 2 | pher | 2025-08 | us | hl7 |
hl7.fhir.us.hai-ltcf | R4 | ImplementationGuide/hl7.fhir.us.hai-ltcf | NHSN Healthcare Associated Infection (HAI) Reports Long Term Care Facilities | draft | 2023-04 | us | hl7 | ||
hl7.fhir.us.hai | R4 | ImplementationGuide/hl7.fhir.us.hai | NHSN Healthcare Associated Infection (HAI) Reports | active | 2023-09 | us | hl7 | ||
hl7.fhir.us.cql | R4 | ImplementationGuide/hl7.fhir.us.cql | Common CQL Artifacts for FHIR (US-Based) | informative | 3 | cds | 2025-07 | us | hl7 |
fhir.cqf.common | R4 | ImplementationGuide/fhir.cqf.common | Clinical Quality Framework Common FHIR Assets | draft | 2021-11 | us | hl7 | ||
hl7.fhir.us.cimilabs | R4 | ImplementationGuide/hl7.fhir.us.cimilabs | Laboratory Base Class FHIR Profiles | draft | 2023-08 | us | hl7 | ||
hl7.fhir.uv.cdisc-mapping | R4 | ImplementationGuide/hl7.fhir.uv.cdisc-mapping | FHIR to CDISC Joint Mapping Implementation Guide | draft | 2024-07 | uv | hl7 | ||
smart.who.int.base-clinical | R4 | ImplementationGuide/smart.who.int.base-clinical | SMART Base Clinical | draft | 2025-06 | uv | who | ||
hl7.fhir.uv.cql | R4 | ImplementationGuide/hl7.fhir.uv.cql | Using CQL With FHIR | trial-use | 4 | cds | 2024-06 | uv | hl7 |
hl7.fhir.uv.cmi | R4 | ImplementationGuide/hl7.fhir.uv.cmi | Content Management Infrastructure Implementation Guide | draft | 2022-05 | uv | hl7 | ||
hl7.fhir.uv.crmi | R4 | ImplementationGuide/hl7.fhir.uv.crmi | Canonical Resource Management Infrastructure Implementation Guide | trial-use | 4 | cds | 2024-05 | uv | hl7 |
hl7.fhir.uv.crmi | R4 | ImplementationGuide/publishable-example | Publishable ImplementationGuide Example | informative | 4 | cds | 2023-07 | uv | hl7 |
hl7.fhir.uv.crmi | R4 | ImplementationGuide/shareable-example | Shareable ImplementationGuide Example | informative | 4 | cds | 2023-07 | uv | hl7 |
hl7.fhir.uv.cql | R4 | ImplementationGuide/example | CQL ImplementationGuide Example | draft | 2023-07 | uv | hl7 | ||
hl7.fhir.us.davinci-alerts | R4 | ImplementationGuide/hl7.fhir.us.davinci-alerts | Da Vinci Unsolicited Notifications | trial-use | 2 | inm | 2025-03 | us | hl7 |
sappatientmanagement.sap_ish_r4_gen | R4 | ImplementationGuide/implementationguideforsappatientmanagementehp8 | IG for SAP Patient Management | draft | |||||
hl7.fhir.us.udap-security | R4 | ImplementationGuide/hl7.fhir.us.udap-security | Security for Scalable Registration, Authentication, and Authorization | trial-use | 4 | sec | 2025-07 | us | hl7 |
hl7.fhir.us.specialty-rx | R4 | ImplementationGuide/hl7.fhir.us.specialty-rx | Specialty Medication Enrollment | active | 2023-05 | us | hl7 | ||
hl7.fhir.us.sdcde | R3 | ImplementationGuide/sdcde | Structured Data Capture - Data Element Exchange | draft | us | hl7 | |||
hl7.fhir.au.ereq | R4 | ImplementationGuide/hl7.fhir.au.ereq | AU eRequesting Implementation Guide | draft | 0 | 2025-06 | au | hl7 | |
hl7.fhir.au.core | R4 | ImplementationGuide/hl7.fhir.au.core | AU Core Implementation Guide | trial-use | 2 | 2025-06 | au | hl7 | |
hl7.fhir.au.base | R4 | ImplementationGuide/hl7.fhir.au.base | AU Base Implementation Guide | trial-use | 2025-06 | au | hl7 | ||
example.fhir.ph.core | R4 | ImplementationGuide/example.fhir.ph.core | PH Core Implementation Guide | draft | 2025-06 | ||||
poc.bonsai.current | R4 | ImplementationGuide/swedishnationalmedicationlist | The Swedish National Medication List, development branch | draft | |||||
hl7.fhir.us.dental-data-exchange | R4 | ImplementationGuide/hl7.fhir.us.dental-data-exchange | Dental Data Exchange | draft | 2025-04 | us | hl7 | ||
smart.who.int.anc | R4 | ImplementationGuide/smart.who.int.anc | WHO Antenatal Care Guideline Implementation Guide | draft | 2017-02 | uv | who | ||
hl7.fhir.us.physical-activity | R4 | ImplementationGuide/hl7.fhir.us.physical-activity | Physical Activity Implementation Guide | trial-use | 2 | pc | 2022-05 | us | hl7 |
hl7.fhir.eu.hdr | R4 | ImplementationGuide/hl7.fhir.eu.hdr | HL7 Europe Hospital Discharge Report | draft | 2025-06 | eu | hl7 | ||
fhir.tx.support.r4 | R4 | ImplementationGuide/fhir.tx.support.r4 | FHIR Terminology Support Package | active | us | hl7 | |||
fhir.tx.support.r3 | R3 | ImplementationGuide/fhir.tx.support.r3 | FHIRTxSupport | active | us | hl7 | |||
hl7.fhir.uv.cmhaffr2 | R5 | ImplementationGuide/hl7.fhir.uv.cmhaffr2 | Consumer Mobile Health Application Functional Framework, Release 2 | informative | 1 | mobile | 2025-05 | uv | hl7 |
hl7.fhir.uv.vhdir | R4 | ImplementationGuide/hl7.fhir.uv.vhdir | Validated Healthcare Directory | trial-use | 2 | pa | 2022-02 | uv | hl7 |
geosalud.UY.implementationGuide | R4 | ImplementationGuide/publishingwithsimplifier.net | GEOSalud Implementation Guide | draft | |||||
cp.test.project.v1-0 | R4 | ImplementationGuide/publishingwithsimplifier.net | CP Test Guide | draft | |||||
MyDummyProject.01 | R4 | ImplementationGuide/mydummyig | MyDummyIG | draft | |||||
hl7.ehrs.uv.ehrsfmr2 | R5 | ImplementationGuide/hl7.ehrs.uv.ehrsfmr2 | HL7 Electronic Health Record System Functional Model, Release 2.1.1 | normative | 1 | ehr | 2025-04 | uv | hl7 |
hl7.ehrs.uv.phrsfmr2 | R5 | ImplementationGuide/hl7.ehrs.uv.phrsfmr2 | HL7 Personal Health Record System Functional Model, Release 2 | normative | 1 | ehr | 2025-04 | hl7 | |
hl7.ehrs.uv.base | R5 | ImplementationGuide/hl7.ehrs.uv.base | Electronic Health Record System Functional Model Base | active | 2025-04 | hl7 | |||
sfm.130323 | R4 | ImplementationGuide/sfmbasisapiimplementationguide1.0 | SFM Basis API Implementation Guide | draft | |||||
sfm.030521 | R4 | ImplementationGuide/sfmbasisapiimplementationguide1.0 | SFM Basis API Implementation Guide | draft | |||||
us.nlm.vsac | R4 | ImplementationGuide/us.nlm.vsac | US VSAC Package | active | us | ||||
ihe.iti.deid | R4 | ImplementationGuide/ihe.iti.deid | De-Identification Profile | draft | 2025-07 | uv | ihe | ||
hl7.fhir.us.davinci-pdex | R4 | ImplementationGuide/hl7.fhir.us.davinci-pdex | Da Vinci Payer Data Exchange | trial-use | 2 | fm | 2025-06 | us | hl7 |
hl7.fhir.us.pacio-cs | R4 | ImplementationGuide/hl7.fhir.us.pacio-cs | PACIO Cognitive Status Implementation Guide | active | 2024-11 | us | hl7 | ||
hl7.fhir.us.pacio-fs | R4 | ImplementationGuide/hl7.fhir.us.pacio-fs | PACIO Functional Status Implementation Guide | active | 2021-11 | us | hl7 | ||
hl7.fhir.us.davinci-pct | R4 | ImplementationGuide/hl7.fhir.us.davinci-pct | Patient Cost Transparency Implementation Guide | trial-use | fm | 2025-08 | us | hl7 | |
hl7.fhir.us.pdmp | R4 | ImplementationGuide/hl7.fhir.us.pdmp | US Prescription Drug Monitoring Program (PDMP) | active | phx | 2024-10 | us | hl7 | |
hl7.fhir.us.safr | R4 | ImplementationGuide/hl7.fhir.us.safr | US Situational Awareness Framework for Reporting (US SAFR) Implementation Guide | trial-use | 1 | pher | 2025-07 | us | hl7 |
odilab.evo | R4 | ImplementationGuide/fhir.odilab | eVerordnung für Hilfs- und Heilmittel | draft | |||||
hl7.eu.fhir.unicom | R5 | ImplementationGuide/hl7.eu.fhir.unicom | UnicomIG | draft | 2025-06 | eu | hl7 | ||
smart.who.int.immunizations | R4 | ImplementationGuide/smart.who.int.immunizations | WHO Immunization Implementation Guide | draft | 2024-12 | who | |||
de.medizininformatikinitiative.kerndatensatz.symptom | R4 | ImplementationGuide/mii-ig-symptom-de-v2024 | MII_IG_Symptom_DE_v2024 | active | de | ||||
de.medizininformatikinitiative.kerndatensatz.studie | R4 | ImplementationGuide/ig-mii-studie-version-1.0 | [DE] Medizininformatik Initiative - Medizinische Forschungsvorhaben - Implementierungsleitfaden - Version 1.0 | active | de | ||||
hl7.fhir.uv.mhealth-framework | R4 | ImplementationGuide/hl7.fhir.uv.mhealth-framework | Application Data Exchange Assessment Framework and Functional Requirements for Mobile Health | active | 2020-04 | uv | hl7 | ||
junk.sample-preview | R4 | ImplementationGuide/sample2.0.1 | Hub 2.0.1 | draft | |||||
devdays.letsbuildafhirspec.simplifier1 | R4 | ImplementationGuide/publishingwithsimplifier.net | Publishing with Simplifier.net | draft | |||||
hl7.fhir.be.core | R4 | ImplementationGuide/hl7.fhir.be.core | eHealth Platform Federal Core Profiles | draft | 2024-06 | be | hl7 | ||
hl7.fhir.be.infsec | R4 | ImplementationGuide/hl7.fhir.be.infsec | eHealth Platform Federal infsec Profiles | active | 2024-11 | be | hl7 | ||
de.gevko.evo.khb | R4 | ImplementationGuide/eHeilmittelverordnung | IG eHeilmittelverordnung | draft | |||||
de.gevko.evo.khb | R4 | ImplementationGuide/igkrankenbefrderung | IG eKrankenbeförderung | draft | |||||
de.gevko.evo.khb | R4 | ImplementationGuide/igekrankenhausbehandlung | IG eKrankenhausbehandlung | draft | |||||
de.gevko.emdaf | R4 | ImplementationGuide/elektronischesmedikations-datenaustauschformat | IG eMedikations-Datenaustauschformat | draft | |||||
hl7.fhir.us.hsds | R4 | ImplementationGuide/hl7.fhir.us.hsds | FHIR Human Services Directory | trial-use | 2 | hss | 2023-10 | us | hl7 |
ezFHIR2.pk | R4 | ImplementationGuide/igtest4 | ig Test | draft | |||||
hl7.fhir.us.mcode | R4 | ImplementationGuide/hl7.fhir.us.mcode | minimal Common Oncology Data Elements (mCODE) Implementation Guide | active | cic | 2025-02 | us | hl7 | |
ihe.iti.dsubm | R4 | ImplementationGuide/ihe.iti.dsubm | Document Subscription for Mobile (DSUBm) | active | 2025-04 | uv | ihe | ||
hl7.fhir.ca.baseline | R4 | ImplementationGuide/hl7.fhir.ca.baseline | Canadian Baseline | draft | 2025-05 | ca | hl7 | ||
ihe.pcc.rsq | R4 | ImplementationGuide/ihe.pcc.rsq | IHE PCC Referral Status Query | draft | 2024-07 | uv | ihe | ||
ihe.domain.profile | R4 | ImplementationGuide/ihe.domain.profile | spelled out name of the IHE Profile | draft | 2025-03 | uv | ihe | ||
ihe.pcc.aps | R4 | ImplementationGuide/ihe.pcc.aps | Antepartum Summary | draft | 2023-10 | uv | ihe | ||
xxxexample.fhir.uv.myig | R4 | ImplementationGuide/xxxexample.fhir.uv.myig | xxxYour User Friendly Name for MyIG Here | draft | 2025-07 | uv | |||
fhir.outburn.co.il | R4 | ImplementationGuide/lab-referral-cycle | Hospital-Community Lab Referral Cycle | draft | us | hl7 | |||
fhir.project0620 | R4 | ImplementationGuide/ImplementationGuide | TestFHIR-project实施指南 | draft | us | hl7 | |||
tsti.adultcheck | R4 | ImplementationGuide/tw.tsti.adultcheck | 成人預防保健實作指引(Adult Check IG) | active | |||||
jp-core.r4 | R4 | ImplementationGuide/hl7.fhir.jp.core | HL7 FHIR JP Core ImplementationGuide | active | 2022-11 | jp | |||
tw.gov.mohw.nhi.pas | R4 | ImplementationGuide/tw.gov.mohw.nhi.pas | 臺灣健保癌症用藥事前審查實作指引 | active | 2025-08 | tw | national | ||
tw.gov.mohw.cdc.twidir | R4 | ImplementationGuide/tw.gov.mohw.cdc.twidir | 臺灣傳染病檢驗報告實作指引 | draft | 2023-10 | tw | national | ||
tw.gov.mohw.twcore | R4 | ImplementationGuide/tw.gov.mohw.twcore | 臺灣核心實作指引(TW Core IG) | active | 2025-05 | tw | national | ||
tw.gov.mohw.nhi.ngs | R4 | ImplementationGuide/tw.gov.mohw.nhi.ngs | 臺灣次世代基因定序檢測實作指引 | active | 2025-07 | tw | national | ||
tw.gov.mohw.nhi.ci | R4 | ImplementationGuide/tw.gov.mohw.nhi.ci | 臺灣重大傷病實作指引 | active | 2025-06 | tw | national | ||
tw.cohesion.fhir.clinemr | R4 | ImplementationGuide/tw.cohesion.fhir.clinemr | 診所門診病摘實作指引 | active | 2024-10 | tw | |||
tw.cathay.fhir.imri | R4 | ImplementationGuide/tw.cathay.fhir.imri | 醫查實作指引 | active | 2024-11 | tw | |||
tw.cathay.fhir.iclaim | R4 | ImplementationGuide/tw.cathay.fhir.iclaim | 醫療保險理賠實作指引 | active | 2023-12 | tw | |||
tw.gov.mohw.emr | R4 | ImplementationGuide/tw.gov.mohw.emr | 電子病歷交換單張實作指引(EMR-IG) | active | 2023-07 | tw | national | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-CPR-1 | Bystander Chest Compressions | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-CPR-10 | TBD | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-CPR-2 | Dispatch coached chest compressions | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-CPR-3 | Time from PSAP to initial compressions | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-CPR-4 | Time to initial shock | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-CPR-5 | Average chest compression rate | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-CPR-6 | Average chest compression depth | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-CPR-7 | Return of Spontaneous Circulation (ROSC)during EMS care | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-CPR-8 | Survival of OHCA with all presenting rhythms | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-CPR-9 | Survival of OHCA when witnessed by bystander | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Hypoglycemia-01 | Treatment Administered for Hypoglycemia | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Hypoglycemia-02 | Improved Post-Treatment Condition | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Hypoglycemia-03 | Hypoglycemic Patients Treated and not Transported | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Hypoglycemia-04 | Repeat Response for Patient Previously Not Transported | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Opioid-01 | Percentage of suspected opioid OD patients who received Narcan | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Opioid-02 | Percentage of suspected opioid OD patients transported to an ED | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Opioid-03 | Percentage of suspected opioid OD patients given multiple Narcan doses in case of an “Unchanged” response to the first dose | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Opioid-04 | Percentage of suspected opioid OD patients experiencing a repeat OD within a specified time period. | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Opioid-05 | Percentage of suspected opioid OD patients with a recorded combination of altered mental status, poor respiratory effort (RR<12 per minute), and pin point pupils. | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Opioid-06 | Percentage of suspected opioid OD patients with a specific opioid recorded | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Opioid-07 | Percentage of suspected opioid OD patients experiencing an Increase in pulse oximetry after EMS care. | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Opioid-08 | Percentage of suspected opioid OD patients experiencing an Increase in Glasgow Coma Scale (GCS) after EMS care. | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Opioid-09 | Percentage of suspected opioid OD patients experiencing an Increase in respiratory rate after EMS care. | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Opioid-10 | Percentage of suspected opioid OD patients who received ventilatory support within five minutes of first EMS unit’s arrival on scene. | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Opioid-11 | Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-PEDS-01 | Respiratory Assessment - Pediatric | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-PEDS-02 | Administration of beta agonist for pediatric asthma | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-PEDS-03 | Documentation of estimated weight in kilograms - pediatric | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-PEDS-04 | Medication error rate | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-STEMI-1 | Time to first EKG | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-STEMI-2 | Time to receiving facility pre-notification | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-STEMI-3 | Transport to PCI/Thrombolytic capable facilities | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-STEMI-4 | Time from First medical contact to receiving facility | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-STEMI-5 | Patients with complete bundle of care | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-STEMI-6 | EMS correctly identified STEMI | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-STEMI-7 | Time to Reperfusion | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Safety-01 | Lights and Sirens Response to Scene Rate | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Safety-02 | Lights and Sirens Transport Rate | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Safety-03 | Number of crashes | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Safety-04 | Number of crashes resulting in injury | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Safety-05 | Number of fatal crashes | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Safety-06 | Rate of crashes per 100,000mi | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Safety-07 | Rate of crashes resulting in injury per 100,000mi | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Safety-08 | Rate of fatalities per 100,000mi | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Seizure-01 | Blood Glucose Evaluation | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Seizure-02 | Patient Received Intervention | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Seizure-03 | Patients with Terminated Seizures | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Stroke-01 | Suspected Stroke Receiving Prehospital Stroke Assessment | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Stroke-02 | Blood Glucose Measurement for Patients with a Provider Impression of Stroke | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Stroke-03 | Prehospital Notification | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Stroke-04 | Positive Stroke Assessments Transported to a Hospital Verified, Designated or Otherwise Identified as Acute Stroke-Ready or Higher | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Stroke-05 | Provider Impression of Stroke with Last Known Well (LKW) Documented | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Stroke-06 | Prehospital Stroke Care Bundle | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Stroke-07 | For Patients with Positive Stroke Assessment, Average Time from Last Known Well to Arrival at a Hospital Verified, Designated or Otherwise Identified as Acute Stroke-Ready or Higher | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Stroke-08 | Emergency Department Diagnosed Stroke Identified by Prehospital Stroke Assessment | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Trauma-01 | Pain assessment of injured patients | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Trauma-02 | Pain re-assessment of injured patients | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Trauma-03 | Effectiveness of pain management for injured patients | unknown | 2024-10 | uv | ihe | ||
ihe.qrph.qore | R4 | Measure/example-IHE-QORE-Trauma-04 | Trauma patients transported to trauma center | unknown | 2024-10 | uv | ihe | ||
ihe.palm.rpc | R4 | Measure/MeasureBreastDistanceFromTheNipple | Breast Distance from the Nipple Rad Path Correlation | draft | 2023-06 | uv | ihe | ||
ihe.palm.rpc | R4 | Measure/MeasureBreastLaterality | Breast Laterality Rad Path Correlation | draft | 2023-06 | uv | ihe | ||
ihe.palm.rpc | R4 | Measure/MeasureBreastLocationOfLesion | Breast Location of Lesion Rad Path Correlation | draft | 2023-06 | uv | ihe | ||
ihe.palm.rpc | R4 | Measure/MeasureBreastQuadrantAndClockFace | Breast Quadrant and Clock Face Rad Path Correlation | draft | 2023-06 | uv | ihe | ||
ihe.palm.rpc | R4 | Measure/MeasureGleason | Gleason Score Rad Path Correlation | draft | 2023-06 | uv | ihe | ||
ihe.palm.rpc | R4 | Measure/MeasureProstateLesionSize | Prostate Lesion Size Rad Path Correlation | draft | 2023-06 | uv | ihe | ||
ihe.palm.rpc | R4 | Measure/MeasureProstateSize | Prostate Size Rad Path Correlation | draft | 2023-06 | uv | ihe | ||
ihe.palm.rpc | R4 | Measure/MeasureProstateTumorLocation | Prostate Tumor Location Rad Path Correlation | draft | 2023-06 | uv | ihe | ||
smart.who.int.hiv | R4 | Measure/HIVIND35 | HIV.IND.35 ARV toxicity prevalence | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND41 | HIV.IND.41 ART coverage in breastfeeding mothers | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND39 | HIV.IND.39 Infant ARV prophylaxis coverage | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND38 | HIV.IND.38 Early infant diagnosis (EID) coverage | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND42 | HIV.IND.42 Final outcome of PMTCT | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND37 | HIV.IND.37 Viral suppression at labour and delivery | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND40 | HIV.IND.40 ART coverage in pregnant women | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND14 | HIV.IND.14 OAMT minimum dose | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND13 | HIV.IND.13 OAMT minimum duration | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND6 | HIV.IND.6 PEP completion | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND7 | HIV.IND.7 HIV in PEP recipients | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND11 | HIV.IND.11 OAMT coverage | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND76 | HIV.IND.76 Presence of STI syndrome, HIV prevention services | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND78 | HIV.IND.78 Repeat diagnosis of STI syndrome, HIV prevention services | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND70 | HIV.IND.70 Gonorrhoea testing coverage, HIV prevention services | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND74 | HIV.IND.74 Gonorrhoea treatment coverage, HIV prevention services | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND66 | HIV.IND.66 Syphilis treatment coverage, HIV prevention services | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND83 | HIV.IND.83 HCV test coverage, HIV prevention services | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND80 | HIV.IND.80 HBV test coverage, HIV prevention services | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND62 | HIV.IND.62 Syphilis test positivity, HIV prevention services | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND58 | HIV.IND.58 Syphilis testing coverage, HIV prevention services | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND88 | HIV.IND.88 HCV positivity, HIV prevention services | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND53 | HIV.IND.53 Multi-month ARV dispensing | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND92 | HIV.IND.92 HCV cured among people living with HIV | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND90 | HIV.IND.90 HBV treatment among people living with HIV | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND91 | HIV.IND.91 HCV treatment among people living with HIV | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND77 | HIV.IND.77 Presence of STI syndrome, HIV-positive clients | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND79 | HIV.IND.79 Repeat diagnosis of STI syndrome, HIV-positive clients | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND57 | HIV.IND.57 Viral suppression among people living with HIV engaged in DSD ART models | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND55 | HIV.IND.55 Coverage of DSD ART models among people living with HIV on ART | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND52 | HIV.IND.52 TB treatment initiation among diagnosed | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND50 | HIV.IND.50 TB testing among those symptom-screened positive | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND51 | HIV.IND.51 TB diagnosis among those tested for TB | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND47 | HIV.IND.47 People living with HIV with active TB disease | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND48 | HIV.IND.48 TB screening coverage among new ART patients | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND49 | HIV.IND.49 TB symptom-screened positive among new ART patients | draft | 2024-08 | who | |||
smart.who.int.hiv | R4 | Measure/HIVIND29 | HIV.IND.29 People living with HIV on ART who have suppressed viral load | draft | 2024-08 | who |